Survival Rates

Negative Margins, Lymph Node Yields Predict Survival

Negative Margins, Lymph Node Yields Predict Survival

Patients with head and neck cancer treated at hospitals attaining the combined metric of a 90 percent or higher negative margin rate and 80% percent of cases achieving a LNY of 18 or more experienced a significant reduction in mortality.

Hospital Volume, Quality Impact Survival in Ovarian Cancer

Hospital Volume, Quality Impact Survival in Ovarian Cancer

Survival rate were worse for lower volume hospitals with higher quality scores, versus higher volume hospitals.

Complete vs Incomplete Metastasectony for mRCC: Improved Survival, Decreased All-Cause Mortality

Complete vs Incomplete Metastasectony for mRCC: Improved Survival, Decreased All-Cause Mortality

By

Complete surgical metastasectomy correlated with increased survival in patients with metastatic renal cell carcinoma (mRCC) compared with incomplete surgical metastasectomy.

Lasting Outcomes for Imatinib in Chronic Myeloid Leukemia

Lasting Outcomes for Imatinib in Chronic Myeloid Leukemia

The efficacy of imatinib for CML treatment persisted over time and long-term administration was not associated with unacceptable cumulative effects.

Nonadherence to Guidelines, Low-Volume Centers Linked to Lower Cervical Cancer Survival

Nonadherence to Guidelines, Low-Volume Centers Linked to Lower Cervical Cancer Survival

By

Nonadherence to NCCN guideline treatment recommendations was strongly associated with decreased survival from early-stage cervical cancer.

Specialized Cancer Centers May Improve Outcomes in Children with Leukemia

Specialized Cancer Centers May Improve Outcomes in Children with Leukemia

By

The site of cancer care may partially explain survival differences between children and AYAs with ALL.

Patients With a Recurrence Score of 11 to 25 May Not Benefit from Chemo

Patients With a Recurrence Score of 11 to 25 May Not Benefit from Chemo

By

Patients with hormone receptor-positive, HER2-negative, axillary lymph node-negative breast cancer who have a recurrence score of 11 to 25 may not benefit from chemotherapy.

Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline

Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline

By

Using statistical models, predictions were made for death rates from melanoma in 3 three countries and based on availability of a treatment.

Adding Bicalutamide to Salvage RT Improves OS in Recurrent Prostate Cancer

Adding Bicalutamide to Salvage RT Improves OS in Recurrent Prostate Cancer

By

Investigators studied the effects of adding antiandrogen therapy to radiotherapy on cancer control and overall survival in men with prostate cancer recurrence after radical prostatectomy.

Side of Origin Affects Colon Cancer Survival

Side of Origin Affects Colon Cancer Survival

Researchers observed a significant disparity in colon cancer mortality related to origin location, independent of confounding variables.

U.S. Health Care System Ranks Among Least Efficient Worldwide

U.S. Health Care System Ranks Among Least Efficient Worldwide

The United States has remained near the bottom of the Bloomberg Health-Care Efficiency Index since its creation in 2012.

EUTOS Registry Represents Benchmark for Evaluation of New CML Treatments

EUTOS Registry Represents Benchmark for Evaluation of New CML Treatments

By

The population-based EUTOS registry demonstrated high overall and progression-free survival rates among patients with chronic myeloid leukemia.

Medicaid Insurance Linked to Worse Outcomes for Patients With Glioblastoma Multiforme

Medicaid Insurance Linked to Worse Outcomes for Patients With Glioblastoma Multiforme

By

Insurance status influences overall patient survival for some cancer types, but its impact on glioblastoma multiforme (GBM) survival is well documented. This research study explored the possible impact of insurance on GBM survival.

Medicaid Insurance Linked to Worse Head and Neck Cancer Outcomes

Medicaid Insurance Linked to Worse Head and Neck Cancer Outcomes

By

A recent study examined the possible correlation between Medicaid coverage status and overall survival for patients with head and neck cancer.

Carfilzomib Increases Survival for Patients With Relapsed Multiple Myeloma

Carfilzomib Increases Survival for Patients With Relapsed Multiple Myeloma

By

A post-hoc analysis of the Phase 3 ASPIRE study indicates that treatment combining carfilzomib with lenalidomide and dexamethasone extended survival time for patients with multiple myeloma.

Evidence Mounts That Low-Dose Aspirin Improves Survival in CRC

Evidence Mounts That Low-Dose Aspirin Improves Survival in CRC

Greatest survival benefit observed for those taking the drug before their cancer diagnosis.

Weekly Paclitaxel Doesn't Increase Survival in Ovarian Cancer

Weekly Paclitaxel Doesn't Increase Survival in Ovarian Cancer

Paclitaxel administered with carboplatin on a weekly basis is not associated with improved progression-free survival.

ICU Survivors Have Higher Five-Year Mortality and Hospital Costs

ICU Survivors Have Higher Five-Year Mortality and Hospital Costs

Intensive care unit survivors have higher mortality, use of hospital resources in five years after discharge.

Minimally Invasive Hysterectomy Linked to Favorable Survival in Uterine Cancer

Minimally Invasive Hysterectomy Linked to Favorable Survival in Uterine Cancer

Use of minimally invasive hysterectomy is linked to favorable morbidity profile and does not compromise long-term survival for patients.

U.S. Cancer Mortality Rates Experience Significant Drop Since 1991

U.S. Cancer Mortality Rates Experience Significant Drop Since 1991

Mortality rate changes in the United States since 1991 translate to an additional 1.7 million cancer survivors.

Surgery and Chemo Combo Optimal for Elderly With Advanced Ovarian Cancer

Surgery and Chemo Combo Optimal for Elderly With Advanced Ovarian Cancer

The longest survival time was observed for primary debulking surgery coupled with chemotherapy in an optimal timeframe.

Early Detection Still Important to Breast Cancer Survival

Early Detection Still Important to Breast Cancer Survival

Despite advances in treatment, finding smaller tumors has been linked to better survival results.

Smokers and Nonsmokers Who Develop NSCLC Display Differences

Smokers and Nonsmokers Who Develop NSCLC Display Differences

Nonsmokers more likely than smokers to be women and to have adenocarcinoma

New Treatment Option May Increase Metastatic Lung Cancer Survival

New Treatment Option May Increase Metastatic Lung Cancer Survival

Patients with metastatic nonsquamous non-small-cell lung cancer treated with nivolumab demonstrated greater survival.

Social factors may impact survival among young patients with leukemia

By

A new study reveals that insurance status, marital status, and county-level income may affect survival for younger patients with AML, indicating that efforts are needed to address social factors that impact critical aspects of health.

Ablation Modality Significantly Increases Survival in Patients With Pancreatic Cancer

Ablation Modality Significantly Increases Survival in Patients With Pancreatic Cancer

By

Use of irreversible electroporation (IRE) doubles survival time for patients with locally advanced pancreatic cancer.

Approximately 30 percent of patients with epithelial ovarian cancer survive long-term

Approximately 30 percent of patients with epithelial ovarian cancer survive long-term

Predictors for long-term survival include younger age, early stage, low grade, non-serous histology

Intraperitoneal chemotherapy improves ovarian cancer survival

Intraperitoneal chemotherapy improves ovarian cancer survival

Despite survival benefits, only 41 percent of suitable candidates actually receive the therapy.

Gene expression and immune system linked with cancer survival rates

By

A recently compiled database that compares gene expression patterns to survival data could help predict survival outcomes for a variety of cancer types.

Effect of radiotherapy on survival of women with locally excised ductal carcinoma in situ of the breast: a Surveillance, Epidemiology, and End Results population-based analysis

Effect of radiotherapy on survival of women with locally excised ductal carcinoma in situ of the breast: a Surveillance, Epidemiology, and End Results population-based analysis

[OncoTargets and Therapy] This research examines the effect of radiotherapy on overall survival in women with locally excised ductal carcinoma in situ (DCIS).

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs